Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Blood-Brain Barrier Bridging Options for Drug Discovery and Development |
May 2008 | £710 | 100% |
| Accelerating Lead Generation Emerging Technologies and Strategies |
Jun 2009 | £2,425 | 99% |
| Early Stage Drug Safety Strategies and Risk Management Maximizing Opportunities towards Achieving Clinical Success |
Apr 2009 | £2,425 | 98% |
| Lead Generation Strategies and Technologies in Drug Development Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs |
Jun 2011 | £2,215 | 94% |
| GPCRs in Drug Discovery Efforts to De-Orphanize Novel Gpcr Targets Are Increasing |
Nov 2011 | £2,215 | 94% |
| Proteomics (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,240 | 92% |
| Innovations in Combating Infectious Diseases Opportunities in Therapeutics and Diagnostics through Application of Proteomics, Genomics, Nanotechnology, and Novel Sources of Lead Generation |
Jun 2010 | £2,425 | 92% |
| The Future of GPCRs in Drug Discovery Novel Technologies, Leading Companies, and Opportunities for Target Expansion |
Apr 2010 | £2,425 | 92% |
| RNAi Technologies, Markets and Companies |
Jan 2012 | £2,590 | 92% |
| Drug Repositioning A market analysis |
Mar 2006 | £1,095 | 90% |
| Biochips Industry forecasts for 2012 & 2017 |
Oct 2008 | £2,910 | 88% |
| Drug Repositioning Strategies Innovative Strategies To Boost Pipeline Productivity |
Jun 2007 | £1,210 | 87% |
| Global Cancer Biomarkers Market (2010 - 2015) | May 2010 | £2,940 | 87% |
| Biomarkers (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,240 | 86% |
| Preclinical Cancer Therapeutics 2007 Decoding Next Generation Drug Targets for Market Success |
Dec 2006 | £1,600 | 86% |
| Drug Discovery Technologies | Jan 2007 | £2,760 | 85% |
| How IT Helps Solve Pharma's R&D Problems in silico Drug Discovery |
Jul 2010 | £2,145 | 85% |
| Next Generation Protein Engineering and Drug Design Strategies to boost efficacy and improve drug delivery |
Feb 2007 | £1,210 | 85% |
| Pharmaceutical Analytical Services Outsourcing in India Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers |
Nov 2010 | £2,215 | 84% |
| Pain Therapeutics Technologies, Markets and Companies |
Jan 2012 | £2,590 | 84% |
| Life Science Tools and Reagents Global Markets |
Apr 2011 | £3,065 | 84% |
| Cell-based Assays: Technologies and Global Markets | May 2011 | £3,065 | 84% |
| Alzheimer's disease Technologies, Markets and Companies |
Jan 2012 | £2,265 | 84% |
| Biomarkers in Drug Discovery Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly |
Oct 2011 | £2,215 | 84% |
| Cancer Profiling and Pathways Technologies and Global Markets |
Sep 2010 | £3,065 | 83% |
| Epigenetics Current and future applications that are driving novel drug discovery |
Aug 2010 | £695 | 83% |
| RNA interference (RNAi) | Apr 2011 | £3,035 | 83% |
| Personalized Medicine (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,240 | 83% |
| Targeting Cancer Stem Cells Therapeutic Strategies and Pipeline Developments (2010) |
Jan 2010 | £1,599 | 83% |
| Targeting Cancer Stem Cells Therapeutic Strategies, Pipeline, Biomarkers and Opportunities (2010) |
Jan 2010 | £1,599 | 83% |
